Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Total Equity

Aerie Pharmaceuticals Total Equity Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Total Equity from 2012 to 2020.
  • Aerie Pharmaceuticals Total Equity for the quarter ending June 06, 2020 was $90m a -132.94% decrease of -119m year over year
  • Aerie Pharmaceuticals Total Equity for the last 12 months ending June 06, 2020 was $90m a -132.94% decrease of -119m year over year
  • Aerie Pharmaceuticals Annual Total Equity for 2019 was $167m a -36.45% decrease of -61m from 2018
  • Aerie Pharmaceuticals Annual Total Equity for 2018 was $228m a 40.48% increase of 92m from 2017
  • Aerie Pharmaceuticals Annual Total Equity for 2017 was $136m a 22.31% increase of 30m from 2016
Other Balance Sheet Metrics:
  • Aerie Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $309m a 6.12% increase of 19m year over year
  • Aerie Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $6m a 11.47% increase of 1m year over year
View Chart On Koyfin

Quarterly AERI Total Equity Data

06/2020$90m
03/2020$127m
12/2019$167m
09/2019$209m
06/2019$156m
03/2019$192m
12/2018$228m
09/2018$269m
06/2018$195m
03/2018$236m

Annual AERI Total Equity Data

2019$167m
2018$228m
2017$136m
2016$105m
2015$19m
2014$28m
2013$67m
2012$-1m
2011$13m